EUVIMEDEUVIMED entdecken
Klinische StudieMultizentrische StudieOpen Access · CC BY 4.0

Cytotoxic CX3CR1+ Vδ1 T cells clonally expand in an interplay of CMV, microbiota, and HIV-1 persistence in people on antiretroviral therapy

Nived Collercandy, Camille Vellas, Manon Nayrac, Mary Requena, Thomas Richarme, Anne-Laure Iscache, Justine Latour, Karl Barange, Laurent Alric, Guillaume Martin-Blondel, Matteo Serino, Jacques Izopet und 1 weitere

PLOS Pathogens · 2025

DOI: 10.1371/journal.ppat.1013489 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift PLOS Pathogens, 2025. Verfasst von Nived Collercandy und 12 weiteren Autor:innen. Beteiligte Einrichtung: INSERM UMR 1291, CNRS UMR 5051, Université de Toulouse, Toulouse Institute for Infectious and Inflammatory Diseases, Toulouse, France. Hauptthemen laut MEDLINE: CX3C Chemokine Receptor 1, Cytomegalovirus, Cytomegalovirus Infections, HIV Infections. Die Arbeit nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: French National Agency for Research on HIV/AIDS and Emerging Infectious Diseases, National Agency for Research on HIV/AIDS and Emerging Infectious Diseases, Sidaction.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vδ 1 γδ T cells are key players in innate and adaptive immunity, particularly at mucosal interfaces such as the gut. An increase in circulating Vδ 1 cells has long been observed in people with HIV-1, but remains poorly understood. We performed a comprehensive characterization of Vδ 1 T cells in blood and duodenal intra-epithelial lymphocytes, obtained from endoscopic mucosal biopsies of 15 people with HIV-1 on antiretroviral therapy and 15 HIV-seronegative controls, in a substudy of the ANRS EP61 GALT study (NCT02906137). We deciphered the phenotype, functional profile, single-cell transcriptome and repertoire of Vδ 1 cells and unraveled their relationships with the possible triggers involved, in particular CMV and microbiota. We also assessed whether Vδ 1 T cells may play a role in controlling the HIV-1 reservoir. Vδ 1 T cells were mainly terminally differentiated effectors that clonally expanded in the blood with some trafficking with the gut of people with HIV-1. Most expressed CX3CR1 and displayed a highly cytotoxic profile, but low cytokine production, supported by a transcriptomic shift towards enhanced effector lymphocytes. This expansion was associated with CMV status and markers of occult replication, but also with changes in the duodenal and blood-translocated microbiota. Cytotoxic, but not IFN-γ-producing, Vδ 1 T cells were negatively associated with cell-associated HIV-1 RNA in both the blood and duodenal compartments. The increase in Vδ1 T cells observed in people with HIV-1 has multiple triggers, particularly CMV and microbiota, and may in turn contribute to the control of the HIV-1 reservoir.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CX3C Chemokine Receptor 1CytomegalovirusCytomegalovirus InfectionsHIV InfectionsHIV-1AdultFemaleHumansMaleMiddle AgedAnti-Retroviral AgentsGastrointestinal MicrobiomeReceptors, Antigen, T-Cell, gamma-delta

Substanzen

Anti-Retroviral AgentsCX3C Chemokine Receptor 1CX3CR1 protein, humanReceptors, Antigen, T-Cell, gamma-delta

Autor:innen und Institutionen

  • INSERM UMR 1291, CNRS UMR 5051, Université de Toulouse, Toulouse Institute for Infectious and Inflammatory Diseases, Toulouse, France.
  • CHU de Toulouse, Service des Maladies Infectieuses et Tropicales, Toulouse, France.
  • CHU de Toulouse, Laboratoire de Virologie, Toulouse, France.
  • CHU de Toulouse, Service d'Hépato-Gastro-Entérologie, Toulouse, France.
  • CHU de Toulouse, Service de Médecine Interne et Immunologie clinique, Toulouse, France.
  • Université de Toulouse, Toulouse, France.

ORCID-Profile: Pierre Delobel

Förderung

  • French National Agency for Research on HIV/AIDS and Emerging Infectious Diseases
  • National Agency for Research on HIV/AIDS and Emerging Infectious Diseases
  • Sidaction

Zitieren

APA

Collercandy, N., Vellas, C., Nayrac, M., Requena, M., Richarme, T., Iscache, A. L., Latour, J., Barange, K., Alric, L., Martin-Blondel, G., Serino, M., Izopet, J., & Delobel, P. (2025). Cytotoxic CX3CR1+ Vδ1 T cells clonally expand in an interplay of CMV, microbiota, and HIV-1 persistence in people on antiretroviral therapy. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1013489

Vancouver

Collercandy N, Vellas C, Nayrac M, Requena M, Richarme T, Iscache AL, et al. Cytotoxic CX3CR1+ Vδ1 T cells clonally expand in an interplay of CMV, microbiota, and HIV-1 persistence in people on antiretroviral therapy. PLOS Pathogens. 2025. doi:10.1371/journal.ppat.1013489

BibTeX
@article{Collercandy2025,
  author = {Collercandy, Nived and Vellas, Camille and Nayrac, Manon and Requena, Mary and Richarme, Thomas and Iscache, Anne-Laure and Latour, Justine and Barange, Karl and Alric, Laurent and Martin-Blondel, Guillaume and Serino, Matteo and Izopet, Jacques and Delobel, Pierre},
  title = {Cytotoxic CX3CR1+ Vδ1 T cells clonally expand in an interplay of CMV, microbiota, and HIV-1 persistence in people on antiretroviral therapy},
  journal = {PLOS Pathogens},
  year = {2025},
  doi = {10.1371/journal.ppat.1013489}
}
Kostenlos starten →